DJIA 15,354.40 121.18 0.80%
NASDAQ 3,498.97 33.73 0.97%
S&P 500 1,667.47 17.00 1.03%

GlaxoSmithKline

NYSE: GSK


company name or ticker
Company Photos
(Click to zoom)

The 3 Deadliest Diseases in the U.S.

These deadly diseases kill more than 1 million Americans every year. But there's still some good news.

This Week in Biotech

Clinical data and abstracts abound ahead of the American Society of Clinical Oncology's annual meeting.

3 Most Important Upcoming FDA Decisions of 2013

The Food and Drug Administration will decide on drugs developed by Merck, Antares Pharmaceuticals, and GlaxoSmithKline in the coming months.

The Billion Dollar COPD Deal: Who Gains The Most?

Cheerleaders: Look Beyond Pharma For Jobs

Time To Show Optimism For Stocks

Amicus Therapeutics: The Good And The Bad

Is AstraZeneca Gearing Up for a Shopping Spree?

With the company's pipeline in turmoil, AstraZeneca looks into the acquisition game.

19 Foreign Stocks With Cheap Valuation And Good Yields

Aveo Screwed Up but Its Kidney Cancer Drug Is Real

See More Articles...